SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000897069-05-002086
Filing Date
2005-08-22
Accepted
2005-08-22 17:07:11
Documents
8

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT cmw1648.htm S-3 248668
2 GRAPHIC ballot.jpg GRAPHIC 751
3 GRAPHIC ballotx.jpg GRAPHIC 762
4 FORM OF SENIOR INDENTURE cmw1648a.htm EX-4.2 364892
5 FORM SUBORDINATED INDENTURE cmw1648b.htm EX-4.3 393543
6 OPINION cmw1648d.htm EX-5.1 29018
7 COMPUTATION OF RATIO cmw1648c.htm EX-12.1 23852
8 CONSENT cmw1648e.htm EX-23.1 1397
  Complete submission text file 0000897069-05-002086.txt   1065007
Mailing Address
Business Address 420 CHIPETA WAY STE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-127756 | Film No.: 051041694
SIC: 2836 Biological Products, (No Diagnostic Substances)